Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)

Clinical trial NCT00950105 · COMPLETED

Trial details

NCT number: NCT00950105
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2009-07-01
Primary completion: 2009-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.